- Home
- NYMTN vs SCLXW Comparison
NYMTN vs SCLXW Comparison
Compare NYMTN & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMTN
- SCLXW
- Stock Information
- Founded
- NYMTN N/A
- SCLXW N/A
- Country
- NYMTN United States
- SCLXW United States
- Employees
- NYMTN 70
- SCLXW 111
- Industry
- NYMTN Real Estate Investment Trusts
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- NYMTN Real Estate
- SCLXW Health Care
- Exchange
- NYMTN Nasdaq
- SCLXW Nasdaq
- Market Cap
- NYMTN N/A
- SCLXW N/A
- IPO Year
- NYMTN N/A
- SCLXW N/A
- Fundamental
- Price
- NYMTN $20.82
- SCLXW $0.10
- Analyst Decision
- NYMTN
- SCLXW
- Analyst Count
- NYMTN 0
- SCLXW 0
- Target Price
- NYMTN N/A
- SCLXW N/A
- AVG Volume (30 Days)
- NYMTN N/A
- SCLXW 4.0K
- Earning Date
- NYMTN N/A
- SCLXW 03-07-2025
- Dividend Yield
- NYMTN N/A
- SCLXW N/A
- EPS Growth
- NYMTN N/A
- SCLXW N/A
- EPS
- NYMTN N/A
- SCLXW N/A
- Revenue
- NYMTN N/A
- SCLXW $55,152,000.00
- Revenue This Year
- NYMTN N/A
- SCLXW N/A
- Revenue Next Year
- NYMTN N/A
- SCLXW N/A
- P/E Ratio
- NYMTN N/A
- SCLXW N/A
- Revenue Growth
- NYMTN N/A
- SCLXW 22.02
- 52 Week Low
- NYMTN N/A
- SCLXW $0.18
- 52 Week High
- NYMTN N/A
- SCLXW $0.18
- Technical
- Relative Strength Index (RSI)
- NYMTN 31.10
- SCLXW N/A
- Support Level
- NYMTN $20.53
- SCLXW N/A
- Resistance Level
- NYMTN $21.50
- SCLXW N/A
- Average True Range (ATR)
- NYMTN 0.25
- SCLXW 0.00
- MACD
- NYMTN -0.07
- SCLXW 0.00
- Stochastic Oscillator
- NYMTN 23.77
- SCLXW 0.00
About NYMTN New York Mortgage Trust Inc. 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.